Celldex (CLDX) Misses Q4 EPS by 7c

Celldex (NASDAQ: CLDX) reported Q4 EPS of ($0.83), $0.07 worse than the analyst estimate of ($0.76). Revenue for the quarter came in at $4.13 million versus the consensus estimate of $855.71 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Celldex to present mast cell targeting drug data at European congress
• Independent Bank receives regulatory approval for HCB Financial acquisition